**Core Concept**
Nasopharyngeal carcinoma is a type of cancer that originates in the nasopharynx, the upper part of the throat behind the nose. The treatment of choice for this condition depends on the stage and extent of the disease, as well as the patient's overall health.

**Why the Correct Answer is Right**
The treatment of choice for nasopharyngeal carcinoma is radiation therapy, particularly intensity-modulated radiation therapy (IMRT). This type of radiation therapy delivers high doses of radiation to the tumor while minimizing damage to surrounding tissues and organs. IMRT is effective in treating nasopharyngeal carcinoma because it can target the tumor with great precision, reducing the risk of complications and improving outcomes.

**Why Each Wrong Option is Incorrect**
**Option A:** Surgery is not the primary treatment for nasopharyngeal carcinoma, as the tumor is often located in a difficult-to-reach area and may not be completely resectable.

**Option B:** Chemotherapy is used in conjunction with radiation therapy to treat nasopharyngeal carcinoma, but it is not the primary treatment.

**Option C:** Nasopharyngeal carcinoma is not typically treated with proton beam therapy, although this may be an option in some cases.

**Clinical Pearl / High-Yield Fact**
It's essential to note that nasopharyngeal carcinoma is more common in certain geographic regions, such as Southeast Asia and North Africa, and is often associated with Epstein-Barr virus infection.

**Correct Answer:** C. Radiation therapy, particularly intensity-modulated radiation therapy (IMRT), is the treatment of choice for nasopharyngeal carcinoma.